The company is gene editing crops to make our food supply more resilient to climate change.
MIT researchers have dramatically lowered the error rate of prime editing, a technique with promise for treating numerous ...
AstraZeneca has signed a $555 million deal with a San Francisco-based biotech business Algen Biotechnologies, The Financial Times reported on Monday.
G lobal pharmaceutical giant AstraZeneca has penned a $555 million with Algen Biotechnologies, a San Francisco-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback